These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6392549)

  • 1. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1984 Oct; 11(5):584-5. PubMed ID: 6392549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of penicillamine-induced glomerular disease.
    Dische FE; Swinson DR; Hamilton EB; Parsons V
    J Rheumatol; 1976 Jun; 3(2):145-54. PubMed ID: 950631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria in D-penicillamine-treated rheumatoid arthritis.
    Crawhall JC
    J Rheumatol Suppl; 1981; 7():161-3. PubMed ID: 6939879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal biopsy appearances in rheumatoid disease.
    Sellars L; Siamopoulos K; Wilkinson R; Leohapand T; Morley AR
    Clin Nephrol; 1983 Sep; 20(3):114-20. PubMed ID: 6627762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.
    Bacon PA; Tribe CR; Mackenzie JC; Verrier-Jones J; Cumming RH; Amer B
    Q J Med; 1976 Oct; 45(180):661-84. PubMed ID: 1005658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complex-type glomerulonephritis with unusual giant deposits in a patient with active rheumatoid arthritis.
    Ohtani H; Wakui H; Komatsuda A; Okuyama S; Masai R; Maki N; Kigawa A; Sawada K
    Clin Exp Nephrol; 2004 Mar; 8(1):63-7. PubMed ID: 15067519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bucillamine induces membranous glomerulonephritis.
    Nagahama K; Matsushita H; Hara M; Ubara Y; Hara S; Yamada A
    Am J Kidney Dis; 2002 Apr; 39(4):706-12. PubMed ID: 11920335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of rheumatoid arthritis with immunotactoid glomerulopathy].
    Katsumata H; Mizuno M; Yamashita H; Kawamura N; Murakami K; Tomita M; Hasegawa M; Yanai T; Kojima K; Kawashima S
    Nihon Jinzo Gakkai Shi; 1992 Aug; 34(8):945-50. PubMed ID: 1484414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis.
    Almirall J; Alcorta I; Botey A; Revert L
    Am J Nephrol; 1993; 13(4):286-8. PubMed ID: 8267029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of penicillamine on the kidney.
    Davison AM; Day AT; Golding JR; Thomson D
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):109-13. PubMed ID: 122655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development and resolution of glomerular basement membrane changes associated with subepithelial immune deposits.
    Törnroth T; Skrifvars B
    Am J Pathol; 1975 May; 79(2):219-36. PubMed ID: 1096633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracapillary glomerulonephritis with necrotizing vasculitis in D-penicillamine-treated rheumatoid arthritis.
    Banfi G; Imbasciati E; Guerra L; Mihatsch MJ; Ponticelli C
    Nephron; 1983; 33(1):56-60. PubMed ID: 6339966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do mesangial immune complex deposits affect the renal prognosis in membranous glomerulonephritis?
    Davenport A; Maciver AG; Hall CL; MacKenzie JC
    Clin Nephrol; 1994 May; 41(5):271-6. PubMed ID: 8050206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesangial disposal of glomerular immune deposits in acute malarial glomerulonephritis of rats.
    Sterzel RB; Ehrich JH; Lucia H; Thomson D; Kashgarian M
    Lab Invest; 1982 Feb; 46(2):209-14. PubMed ID: 7038293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal immunoglobulin G1-kappa fibrillary glomerulonephritis.
    Grove P; Neale PH; Peck M; Schiller B; Haas M
    Mod Pathol; 1998 Jan; 11(1):103-9. PubMed ID: 9556416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial isolated C3 deposition in patients with recurrent or persistent hematuria.
    Orfila C; Pieraggi MT; Suc JM
    Lab Invest; 1980 Jul; 43(1):1-8. PubMed ID: 6993785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
    Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
    Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glomerulopathy in rheumatic patients due to penicillamine].
    Muller V; Krumhaar I; Schneider W; Ditscherlein G
    Allerg Immunol (Leipz); 1976; 22(3):291-5. PubMed ID: 139094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal immunoglobulin deposition disease associated with membranous features.
    Komatsuda A; Masai R; Ohtani H; Togashi M; Maki N; Sawada K; Wakui H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3888-94. PubMed ID: 18596130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.